RxDoctor Payments DataLook up a doctor →

Larry Flake, MD

Family Medicine · Shreveport, LANPI 1386670917

Payments from drug & device makers

$20,048in general payments, 2019–2025

Across 1,185 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Biohaven Pharmaceutical Holding Company Ltd.$2K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$1K
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)263$3,185
Biohaven Pharmaceutical Holding Company Ltd.14$1,836
AstraZeneca(2 entities)98$1,653
Novo Nordisk67$1,383
Lilly USA, LLC85$1,234
Boehringer Ingelheim71$1,024
Pfizer75$979
Amgen(2 entities)62$965
GSK56$853
Takeda Pharmaceuticals U.S.A., Inc.52$807
Merck41$590
Bayer32$560
Johnson & Johnson24$401
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$355
Axsome Therapeutics, Inc.16$307
Astellas Pharma US Inc9$279
Daiichi Sankyo Inc.13$269
Amarin Pharma, Inc.15$254
Avanir Pharmaceuticals, Inc.6$215
Phathom Pharmaceuticals, Inc.10$199
Kowa Pharmaceuticals America, Inc.14$198
Ironshore Pharmaceuticals Inc.9$178
Sanofi-aventis U.S. LLC13$174
Corium, LLC7$171
Teva Pharmaceuticals USA, Inc.12$156
Biohaven Pharmaceuticals, Inc.9$133
Lundbeck LLC6$131
Supernus Pharmaceuticals, Inc.6$120
Otsuka America Pharmaceutical, Inc.5$102
Idorsia Pharmaceuticals US Inc5$96
Dexcom, Inc.4$92
Esperion Therapeutics, Inc.5$90
Abbott6$88
Shield Therapeutics Inc5$85
Sumitomo Pharma America, Inc.2$85
Exact Sciences4$74
IBSA Pharma Inc.4$72
Collegium Pharmaceutical, Inc.4$62
Mannkind Corporation1$59
Tris Pharma Inc3$54
Ardelyx, Inc.3$50
Corcept Therapeutics2$49
Recor Medical Inc2$37
Abiomed1$32
Shire North American Group Inc2$32
Neos Therapeutics, LP2$30
Inogen, Inc.2$27
Tonix Medicines, Inc.1$22
Vanda Pharmaceuticals Inc.1$21
Antares Pharma, Inc.1$20
Xeris Pharmaceuticals, Inc.1$19
Itamar Medical Inc1$18
Jazz Pharmaceuticals Inc.1$18
Arbor Pharmaceuticals, Inc.1$18
Harmony Biosciences LLC1$16
Boston Scientific1$16
Adlon Therapeutics L.p.1$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Upsher-smith Laboratories LLC1$12
Eisai Inc.1$11

How this compares

$20,048 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$91,461
Medicare patients
258
Services billed
1,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →